NCT02254369View on ClinicalTrials.gov

Safety, Tolerability, and Pharmacokinetic Study of Single Ascending Doses of GC021109 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

44

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions

Healthy Volunteers

Interventions

DRUG

GC021109

OTHER

Placebo

Trial Locations (1)

07753

Celerion, Neptune City

Sponsors

Lead Sponsor

All Listed Sponsors

lead

GliaCure, Inc.

INDUSTRY